Cargando…
MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
Serum levels of liver enzymes, such as alanine transaminase, aspartate transaminase, and α-fetoprotein, provide insight into liver function and are used during treatment of liver disease, but such information is limited. In the case of hepatocellular carcinoma (HCC), which is often not detected unti...
Autores principales: | Hayes, C. Nelson, Chayama, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813144/ https://www.ncbi.nlm.nih.gov/pubmed/26927063 http://dx.doi.org/10.3390/ijms17030280 |
Ejemplares similares
-
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Afonso, Marta B., et al.
Publicado: (2016) -
MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas
por: Anwar, Sumadi Lukman, et al.
Publicado: (2015) -
Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
por: Sorop, Andrei, et al.
Publicado: (2021) -
The Role of MicroRNAs in Hepatocellular Carcinoma
por: Xu, Xin, et al.
Publicado: (2018) -
Exosomal microRNAs in hepatocellular carcinoma
por: Liu, Chenbin, et al.
Publicado: (2021)